Subramanian Sanjay
- SEC CIK
- 0001790246
No open-market purchases or sales filed in the past year.
Current role at each company
- SCYX Scynexis IncChief Financial Officeras of Sep 11, 2026
- INZY Inozyme Pharma, Inc.SVP, CFO & Head of BDas of Jul 3, 2025
- OCGN Ocugen, Inc.Chief Financial Officeras of Jan 5, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Subramanian Sanjay as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INZY Inozyme Pharma, Inc.
SVP, CFO & Head of BD1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Subramanian SanjaySVP, CFO | PPurchase | +27.1K | $3.69 | +$100.0K | New position27.1K after |
OCGN Ocugen, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2021 (view filing) | Oct 26 | 1 day | Subramanian SanjayChief Financial Officer | SSale | −10.0K | $11.07 | −$110.7K | −21.9%35.6K after | |
| Oct 15, 2021 (view filing) | Oct 15 | Same day | Subramanian SanjayChief Financial Officer | SSale | −7.99K | $9.96 | −$79.6K | −14.9%45.6K after | |
| Aug 18, 2021 (view filing)4:01 PM ET | Aug 16 | 2 days | Subramanian SanjayChief Financial Officer | SSale | −30.0K | $7.22 | −$216.6K | −39.7%45.6K after | |
| Jul 16, 2021 (view filing)4:01 PM ET | Jul 15 | 1 day | Subramanian SanjayChief Financial Officer | SSale | −31.1K | $6.70 | −$208.3K | −40.5%45.6K after |